Author

Ivan S. Kotchetkov

Memorial Sloan Kettering Cancer CenterORCID 0000-0001-6202-9528Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Ebba SohlbergiD· 1 shared Jorge Mansilla‐SotoiD· 1 shared Karl‐Johan MalmbergiD· 1 shared Lamberto Torralba‐RagaiD· 1 shared Michel SadelainiD· 1 shared Michelle Sætersmoen· 1 shared Quirin HammeriD· 1 shared Silje Zandstra KrokeideiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Ebba SohlbergORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ImmunologyMedPeer-reviewedOct 17, 2024

Targeting HLA-E Positive Cancers with a Novel NKG2A/C Switch Receptor

Michelle Sætersmoen, Ivan S. Kotchetkov, Lamberto Torralba‐Raga…·Karl‐Johan Malmberg

This paper develops a novel chimeric A/C switch receptor to target HLA-E positive cancers, showing enhanced anti-tumor activity while avoiding off-tumor toxicity.

33 citationstop 4%

humanproteomics

𝕏 PostBluesky